Dr. Alexandre Brkovic serves as Vice President of Clinical Research at Thryv Therapeutics, bringing over a decade of experience in the pharmaceutical industry across project management, clinical operations, and pharmacokinetics.

Prior to joining Thryv, Dr. Brkovic was Senior Manager of Clinical Trials at Bausch Health (and later Bausch + Lomb following its spin-off), where he managed medical device and pharmaceutical studies spanning Phase 1 to 4 across multiple therapeutic areas, including dermatology, ophthalmology, and infectious diseases. Before that, he was Manager of Clinical Trials at Jubilant DraxImage, overseeing a therapeutic radiopharmaceutical investigational product in Phase 2, Phase 3, and an expanded access program for an ultra-rare pediatric oncology disease.

Dr. Brkovic began his pharmaceutical career at Pharmascience, where he held roles of increasing responsibility. Before his departure, he served as Director of Biopharmaceutics, leading clinical trial execution and managing a team of scientists and clinical research associates.

Dr. Brkovic holds a bachelor's degree in Biochemistry from the Université du Québec à Montréal (UQAM), a master's degree in Experimental Health Sciences from INRS-Institute Armand-Frappier, and a PhD in Pharmacology from the Université de Montréal (UdeM).